Clinical trial NCT02644356: Complementary Therapies in Palliative Care
Official title: Palliative Care Provider Online Education in Evidence-Based Complementary Therapies
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE1
Conditions: Health Care Provider Education
Lead sponsor: Collinge and Associates, Inc.
Sponsor class: OTHER
Collaborators: name: Kozak & Associates, LLC
First posted: 2015-12-31
Enrollment: 51
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: Palliative care represents one of the most rapidly expanding sectors of health care. Its rapid growth has been accompanied by widespread needs for training of multidisciplinary personnel to work with the unique set of health issues specific to its population of patients - not only those at end-of-life, but also patients with long-term, incurable, chronic and degenerative illnesses. This project will develop the first online continuing education program for palliative care personnel in the evidence-based application of complementary therapies, to enhance patient care and quality of life in the palliative care setting.

Detailed description: Palliative care represents one of the most rapidly expanding sectors of health care. Its rapid growth has been accompanied by widespread needs for training of multidisciplinary personnel to work with the unique set of health issues specific to its population of patients - not only those at end-of-life, but also patients with long-term, incurable, chronic and degenerative illnesses. Selected complementary therapies offer significant benefits for reducing suffering and improving quality of life in palliative care patients; however, there currently are no systematic educational offerings on the evidence-based application of such therapies in the palliative care setting. This project will develop the first online continuing education program for palliative care personnel in the evidence-based application of complementary therapies in the palliative care setting. The final product will consist of an interactive course with eight modules; Phase I will develop the web infrastructure for the course, and will then pilot test two modules to establish feasibility of the concept. The specific aims are as follows: Aim 1. Build a website capable of delivering an online interactive educational curriculum. Aim 2. Conduct evidence-based reviews of the literature on the application of complementary therapies to pain and dyspnea in palliative care settings. Aim 3. Incorporate the course content into a structure and form that can be effectively delivered over the website. Aim 4. Conduct peer review evaluation of content to determine fidelity of course content with available evidence. Aim 5. Recruit a multidisciplinary sample of health care personnel practicing in the field of palliative care. Aim 6. Conduct pilot testing of two modules of the program. Aim 7. Evaluate {attitudinal and} learning outcomes and user satisfaction feedback to determine feasibility of the approach. Feasibility of the approach will be determined by success in recruitment, compliance, evidence of meeting user learning objectives, and user satisfaction data. The final product to be developed is an eight-module online educational course for multidisciplinary health professionals in the evidence-based application of complementary therapies in palliative care. Commercial application will be as a continuing education program that is licensed to institutions (care facilities, hospitals, universities, colleges) as well as purchased by individual users (fee-based), with discipline-specific continuing education credits available, all administered over the internet. Impact and Innovation: This will be the first online educational program for palliative care personnel on this topic available in the US. The course will spearhead the expansion of the existing paradigm of palliative care to incorporate evidence-based integration of complementary therapies. Technological innovation includes the employment of fluid updating of content to licensees, which is a new development in online education and particularly important given the rapid rate of emergence of new data. Public health benefit: The course will aid in the improvement of quality of palliative care, benefitting potentially millions of recipients in the most rapidly expanding sector of the health care system.

Eligibility criteria: Inclusion Criteria:

* Physicians (MD, DO), physician assistant (PA), nurse practitioner (NP), registered nurse (RN), licensed practical nurse (LPN), social worker (BA/BS/BSW, MSW, PhD/DSW), psychologist (MS/MA, PhD/PsyD), counselor (MS/MA),administrator, and chaplain.
* Must be currently active within palliative care settings.

Exclusion Criteria:

* Professionals not actively working in palliative care settings

Primary outcomes:
measure: Change in Test Scores on Knowledge of Course Content From Baseline to 30 Days
timeFrame: Baseline, 30 days
Secondary outcomes:
measure: Change in Ratings of Confidence in Understanding a Modality's Safety Considerations in PC From Baseline to 30 Days
timeFrame: Baseline, 30 days
measure: Change in Ratings of Confidence in Making Evidence-based Recommendations for the Modality in PC Planning From Baseline to 30 Days
timeFrame: Baseline, 30 days
measure: Change in Ratings of Confidence in Explaining the Modality From Baseline to 30 Days
timeFrame: Baseline, 30 days
measure: Perceived Course Relevance: Importance of Knowledge About Non-pharmacological Approaches
timeFrame: 30 day follow-up
measure: Perceived Course Relevance: Increasing Knowledge of Non-pharmacological Approaches
timeFrame: 30 day follow-up
measure: Perceived Course Relevance: Potential of Course to Contribute to Improved Patient Care
timeFrame: 30 day follow-up
Other outcomes:
Locations:
Study officials:
affiliation: Collinge and Associates, Inc.
name: William B Collinge, PhD, MPH
role: PRINCIPAL_INVESTIGATOR
References: